Evidence map›Paper›PMID 34532041›Full record

ArticleClinical case reports2021

Impaired glucose tolerance with neurological manifestations in insulinoma.

Luis Geraldine Villanueva-Rodríguez, Alfredo Adolfo Reza-Albarrán, Enrique Cárdenas, Arturo Ángeles, Jacobo Lester

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Luis Geraldine Villanueva-RodríguezInternal Medicine/Endocrinology Hospital Angeles Lomas Huixquilucan Mexico.ORCID https://orcid.org/0000-0003-4829-344X
Alfredo Adolfo Reza-AlbarránEndocrinology Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" Tlalpan Mexico.ORCID https://orcid.org/0000-0002-3732-8726
Enrique CárdenasNeurology/Neurophysiology Instituto Mexicano de Neurociencias/Hospital Angeles Lomas Huixquilucan Mexico.
Arturo ÁngelesPahology Department Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" Tlalpan Mexico.
Jacobo LesterNeurology Instituto Mexicano de Neurociencias Huixquilucan Mexico.ORCID https://orcid.org/0000-0002-6890-4108
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXMexican Association for the Clinical Research · MXUniversidad Anáhuac · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulinoma may have an atypical presentation and it should be suspected in patients with neurological manifestations in spite of an atypical insulin and proinsulin levels associated with hypoglycemia. Fast test is an important tool to reach the diagnosis.

Indexed as

hypoglycemiainsulinomaneurological symptomsproinsulin

Identifiers

PMID34532041
PMCPMC8435222
OpenAlexW3200832259

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.